Cargando…

Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys

BACKGROUND: The Omicron wave of COVID-19 in England peaked in January 2022 resulting from the rapid transmission of the Omicron BA.1 variant. We investigate the spread and dynamics of the SARS-CoV-2 epidemic in the population of England during February 2022, by region, age and main SARS-CoV-2 sub-li...

Descripción completa

Detalles Bibliográficos
Autores principales: Chadeau-Hyam, Marc, Tang, David, Eales, Oliver, Bodinier, Barbara, Wang, Haowei, Jonnerby, Jakob, Whitaker, Matthew, Elliott, Joshua, Haw, David, Walters, Caroline E., Atchison, Christina, Diggle, Peter J., Page, Andrew J., Ashby, Deborah, Barclay, Wendy, Taylor, Graham, Cooke, Graham, Ward, Helen, Darzi, Ara, Donnelly, Christl A., Elliott, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330654/
https://www.ncbi.nlm.nih.gov/pubmed/35915784
http://dx.doi.org/10.1016/j.lanepe.2022.100462
_version_ 1784758214988922880
author Chadeau-Hyam, Marc
Tang, David
Eales, Oliver
Bodinier, Barbara
Wang, Haowei
Jonnerby, Jakob
Whitaker, Matthew
Elliott, Joshua
Haw, David
Walters, Caroline E.
Atchison, Christina
Diggle, Peter J.
Page, Andrew J.
Ashby, Deborah
Barclay, Wendy
Taylor, Graham
Cooke, Graham
Ward, Helen
Darzi, Ara
Donnelly, Christl A.
Elliott, Paul
author_facet Chadeau-Hyam, Marc
Tang, David
Eales, Oliver
Bodinier, Barbara
Wang, Haowei
Jonnerby, Jakob
Whitaker, Matthew
Elliott, Joshua
Haw, David
Walters, Caroline E.
Atchison, Christina
Diggle, Peter J.
Page, Andrew J.
Ashby, Deborah
Barclay, Wendy
Taylor, Graham
Cooke, Graham
Ward, Helen
Darzi, Ara
Donnelly, Christl A.
Elliott, Paul
author_sort Chadeau-Hyam, Marc
collection PubMed
description BACKGROUND: The Omicron wave of COVID-19 in England peaked in January 2022 resulting from the rapid transmission of the Omicron BA.1 variant. We investigate the spread and dynamics of the SARS-CoV-2 epidemic in the population of England during February 2022, by region, age and main SARS-CoV-2 sub-lineage. METHODS: In the REal-time Assessment of Community Transmission-1 (REACT-1) study we obtained data from a random sample of 94,950 participants with valid throat and nose swab results by RT-PCR during round 18 (8 February to 1 March 2022). FINDINGS: We estimated a weighted mean SARS-CoV-2 prevalence of 2.88% (95% credible interval [CrI] 2.76–3.00), with a within-round effective reproduction number (R) overall of 0.94 (0·91–0.96). While within-round weighted prevalence fell among children (aged 5 to 17 years) and adults aged 18 to 54 years, we observed a level or increasing weighted prevalence among those aged 55 years and older with an R of 1.04 (1.00–1.09). Among 1,616 positive samples with sublineages determined, one (0.1% [0.0–0.3]) corresponded to XE BA.1/BA.2 recombinant and the remainder were Omicron: N=1047, 64.8% (62.4–67.2) were BA.1; N=568, 35.2% (32.8–37.6) were BA.2. We estimated an R additive advantage for BA.2 (vs BA.1) of 0.38 (0.34–0.41). The highest proportion of BA.2 among positives was found in London. INTERPRETATION: In February 2022, infection prevalence in England remained high with level or increasing rates of infection in older people and an uptick in hospitalisations. Ongoing surveillance of both survey and hospitalisations data is required. FUNDING: Department of Health and Social Care, England.
format Online
Article
Text
id pubmed-9330654
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-93306542022-07-28 Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys Chadeau-Hyam, Marc Tang, David Eales, Oliver Bodinier, Barbara Wang, Haowei Jonnerby, Jakob Whitaker, Matthew Elliott, Joshua Haw, David Walters, Caroline E. Atchison, Christina Diggle, Peter J. Page, Andrew J. Ashby, Deborah Barclay, Wendy Taylor, Graham Cooke, Graham Ward, Helen Darzi, Ara Donnelly, Christl A. Elliott, Paul Lancet Reg Health Eur Articles BACKGROUND: The Omicron wave of COVID-19 in England peaked in January 2022 resulting from the rapid transmission of the Omicron BA.1 variant. We investigate the spread and dynamics of the SARS-CoV-2 epidemic in the population of England during February 2022, by region, age and main SARS-CoV-2 sub-lineage. METHODS: In the REal-time Assessment of Community Transmission-1 (REACT-1) study we obtained data from a random sample of 94,950 participants with valid throat and nose swab results by RT-PCR during round 18 (8 February to 1 March 2022). FINDINGS: We estimated a weighted mean SARS-CoV-2 prevalence of 2.88% (95% credible interval [CrI] 2.76–3.00), with a within-round effective reproduction number (R) overall of 0.94 (0·91–0.96). While within-round weighted prevalence fell among children (aged 5 to 17 years) and adults aged 18 to 54 years, we observed a level or increasing weighted prevalence among those aged 55 years and older with an R of 1.04 (1.00–1.09). Among 1,616 positive samples with sublineages determined, one (0.1% [0.0–0.3]) corresponded to XE BA.1/BA.2 recombinant and the remainder were Omicron: N=1047, 64.8% (62.4–67.2) were BA.1; N=568, 35.2% (32.8–37.6) were BA.2. We estimated an R additive advantage for BA.2 (vs BA.1) of 0.38 (0.34–0.41). The highest proportion of BA.2 among positives was found in London. INTERPRETATION: In February 2022, infection prevalence in England remained high with level or increasing rates of infection in older people and an uptick in hospitalisations. Ongoing surveillance of both survey and hospitalisations data is required. FUNDING: Department of Health and Social Care, England. Elsevier 2022-07-28 /pmc/articles/PMC9330654/ /pubmed/35915784 http://dx.doi.org/10.1016/j.lanepe.2022.100462 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
Chadeau-Hyam, Marc
Tang, David
Eales, Oliver
Bodinier, Barbara
Wang, Haowei
Jonnerby, Jakob
Whitaker, Matthew
Elliott, Joshua
Haw, David
Walters, Caroline E.
Atchison, Christina
Diggle, Peter J.
Page, Andrew J.
Ashby, Deborah
Barclay, Wendy
Taylor, Graham
Cooke, Graham
Ward, Helen
Darzi, Ara
Donnelly, Christl A.
Elliott, Paul
Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys
title Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys
title_full Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys
title_fullStr Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys
title_full_unstemmed Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys
title_short Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys
title_sort omicron sars-cov-2 epidemic in england during february 2022: a series of cross-sectional community surveys
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330654/
https://www.ncbi.nlm.nih.gov/pubmed/35915784
http://dx.doi.org/10.1016/j.lanepe.2022.100462
work_keys_str_mv AT chadeauhyammarc omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT tangdavid omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT ealesoliver omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT bodinierbarbara omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT wanghaowei omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT jonnerbyjakob omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT whitakermatthew omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT elliottjoshua omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT hawdavid omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT walterscarolinee omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT atchisonchristina omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT digglepeterj omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT pageandrewj omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT ashbydeborah omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT barclaywendy omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT taylorgraham omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT cookegraham omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT wardhelen omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT darziara omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT donnellychristla omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys
AT elliottpaul omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys